M. Povero, L. Pradelli, A. Serra, F. Fanelli, and L. Gazzi, “Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy”, FE, vol. 22, no. 1, Jun. 2021.